Topic: GlaxoSmithKline plc
A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of ...
Diabetes drug Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems. The committee, convened at the request of the Food and Drug ...
British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who ...
UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting ...
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food ...
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food ...
WASHINGTON (Reuters) - A heated three-year safety debate about a GlaxoSmithKline Plc diabetes pill reaches a climax this week as opponents and backers face off at a U.S. meeting that will help decide the drug's fate. A panel of scientific experts meets ...
European Medicines Agency to review safety of GlaxoSmithKline's diabetes drug AvandiaThe European Medicines Agency says it will review the safety of the diabetes drug Avandia following research suggesting it is linked to a higher risk of heart problems, strokes and deaths in ...
LONDON (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week. The European Medicines Agency (EMA) said on ...
WASHINGTON (Reuters) - Low doses of GlaxoSmithKline's diabetes drug Avandia combined with metformin can prevent diabetes without causing the most common side-effects, Canadian doctors reported on Wednesday. Taking half a dose of Glaxo's combination pill reduced by two-thirds the risk that patients ...
Photo Gallery
From Around the Web
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13 -
News Update: GlaxoSmithKline to Pay Over ...
GlaxoSmithKline Plc (GSK) will pay pay more than $1 billion ...2010-07-20
